Horama, created in March 2014, is developing new gene therapies for the treatment of hereditary retinopathies pigmentosa, which are orphan ophthalmological diseases. Horama is a specialist in ophthalmic diseases gene therapy.
Company (Alive / Active)
Phone: +33 (0)9 53 73 68 15
27 rue du Faubourg Saint-Jacques
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)